Compare CENTA & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CENTA | BCRX |
|---|---|---|
| Founded | 1955 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 1993 | 1994 |
| Metric | CENTA | BCRX |
|---|---|---|
| Price | $30.34 | $7.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $36.50 | $19.00 |
| AVG Volume (30 Days) | 392.3K | ★ 3.9M |
| Earning Date | 11-24-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.41 | N/A |
| EPS | ★ 2.55 | N/A |
| Revenue | ★ $3,129,064,000.00 | $599,816,000.00 |
| Revenue This Year | $2.20 | $40.20 |
| Revenue Next Year | $2.10 | $7.71 |
| P/E Ratio | $11.87 | ★ N/A |
| Revenue Growth | N/A | ★ 45.38 |
| 52 Week Low | $25.97 | $6.00 |
| 52 Week High | $37.35 | $11.31 |
| Indicator | CENTA | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.69 | 57.62 |
| Support Level | $29.62 | $7.51 |
| Resistance Level | $31.39 | $7.98 |
| Average True Range (ATR) | 0.95 | 0.33 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 47.60 | 60.41 |
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.